次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

分子標的薬:世界市場2026年予測

Targeted Therapeutics Market

出版元:BCC ResearchLinkIcon出版元について
発行年:2021年10月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文156ページになります。
商品コード:BCC314

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
分子標的薬の世界市場規模は、2021年の1,009億ドルから2026年に1,426億ドルへと漸増が見込まれます。
当レポートでは、分子標的薬の市場/技術的背景、COVID-19による分子標的薬市場への影響、規制面、各種セグメント別市場分析(種類別、用途別、国地域別)、業界構造、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場概要

・がんの負担
・がんの原因
・がんの原因となる遺伝子
・免疫系とがん
・がん予防
・がん治療の種類
・市場ダイナミクス(ドライバー、障壁、機会)

◆COVID-19による分子標的薬市場への影響

・COVID-19によるがん治療への影響

◆規制面

・米国
・欧州
・日本
・インド
・中国

◆分子標的薬市場、種類別

・小分子
・モノクローナル抗体
※市場予測データ-2026年掲載

◆分子標的薬市場、用途別

・肺がん
・乳がん
・血液がん
・結腸直腸がん
・その他がん
※市場予測データ-2026年掲載

◆分子標的薬市場、国地域別

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※市場予測データ-2026年掲載
※地域別に種類別、用途別の細分化データ掲載

◆業界構造

・競合状況
・パイプライン分析

◆主要企業プロフィール

・AMGEN INC.
・ASTRAZENECA
・BAYER AG
・BOEHRINGER INGELHEIM INTERNATIONAL GMBH
・BRISTOL-MYERS SQUIBB
・F. HOFFMANN-LA ROCHE LTD.
・MERCK & CO., INC.
・NOVARTIS AG
・PFIZER
・武田薬品工業株式会社

(全156頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Targeted Therapeutics Market

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Market Size and Evolution

Chapter 3 Market Overview

Cancer Burden
Causes of Cancer

  • Genetic Factors
  • Lifestyle Factors
  • Environmental Factors

Cancer-Causing Genes
Immune System and Cancer
Cancer Prevention
Types of Cancer Treatment

  • Non-pharmacological Approaches
  • Pharmacological Approaches
  • Gene Therapy

Market Dynamics

  • Drivers
  • Restraints
  • Opportunity

Chapter 4 Impact of COVID-19 on Market

Overview

  • Current Outlook

Impact of COVID-19 on Cancer Care

Chapter 5 Regulatory Aspects

Overview
United States

  • New Drug Application (NDA)
  • Fast-Track Status

Europe
Japan
India

  • New Drug Approval
  • Import Registration Certificate
  • Import License

China

Chapter 6 Market Breakdown by Type of Targeted Therapy

Overview
Small Molecules

  • Market Size and Forecast
  • Market Analysis

Monoclonal Antibodies

  • Market Size and Forecast
  • Market Analysis

Chapter 7 Market Breakdown by Application

Overview
Lung Cancer

  • Market Size and Forecast
  • Market Analysis

Breast Cancer

  • Market Size and Forecast
  • Market Analysis

Blood Cancer

  • Market Size and Forecast
  • Market Analysis

Colorectal Cancer

  • Market Size and Forecast
  • Market Analysis

Other Cancers

  • Market Size and Forecast
  • Market Analysis

Chapter 8 Market Breakdown by Region

Introduction
North America

  • Market Analysis
  • U.S.
  • Canada

Europe

  • Market Impact
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • Market Analysis
  • China
  • India
  • Japan
  • Rest of Asia-Pacific

Rest of the World

  • Market Size and Forecast

Chapter 9 Industry Structure

Company Landscape
Pipeline Analysis

  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV Clinical Trials

Chapter 10 Company Profiles

AMGEN INC.
ASTRAZENECA
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO., INC.
NOVARTIS AG
PFIZER
TAKEDA PHARMACEUTICAL CO., LTD.
Chapter 11 Appendix: Acronyms

List of Tables

Summary Table : Global Market for Targeted Therapeutics, by Type, Through 2026
Table 1 : Cancer Treatment Types
Table 2 : Cancer Treatment Strategy Timeline
Table 3 : List of Cancer Drug/Imaging Agent Approvals, 2020
Table 4 : Patent Expiration Dates, Targeted Therapy Drugs
Table 5 : Side Effects of Targeted Therapies
Table 6 : Coronavirus Reported Cases and Deaths, by Country, 2020
Table 7 : FDA Approval Date, Selected Targeted Therapeutic Drugs
Table 8 : Global Market for Targeted Therapeutics, by Type, Through 2026
Table 9 : Global Market for Cancer Small Molecule Therapy, by Region, Through 2026
Table 10 : Selected Small Molecule Inhibitors for Cancer Therapy
Table 11 : Global Market for Cancer Monoclonal Antibody Therapy, by Region, Through 2026
Table 12 : Selected Approved/Under-Review MAB Cancer Therapeutics in the U.S. and EU
Table 13 : Global Market for Targeted Therapeutics, by Application, Through 2026
Table 14 : Global Market for Targeted Therapeutics for Lung Cancer, by Region, Through 2026
Table 15 : Some Targeted Therapeutics for Lung Cancer
Table 16 : Global Market for Targeted Therapeutics for Breast Cancer, by Region, Through 2026
Table 17 : Global Market for Targeted Therapeutics for Blood Cancer, by Region, Through 2026
Table 18 : Global Market for Targeted Therapeutics for Colorectal Cancer, by Region, Through 2026
Table 19 : Global Market for Targeted Therapeutics for Other Types of Cancer, by Region, Through 2026
Table 20 : Global Market for Targeted Therapeutics, by Region, Through 2026
Table 21 : North American Market for Targeted Therapeutics, by Type, Through 2026
Table 22 : North American Market for Targeted Therapeutics, by Application, Through 2026
Table 23 : North American Market for Targeted Therapeutics, by Country, Through 2026
Table 24 : European Market for Targeted Therapeutics, by Type, Through 2026
Table 25 : European Market for Targeted Therapeutics, by Application, Through 2026
Table 26 : European Market for Targeted Therapeutics, by Country, Through 2026
Table 27 : Asia-Pacific Market for Targeted Therapeutics, by Type, Through 2026
Table 28 : Asia-Pacific Market for Targeted Therapeutics, by Application, Through 2026
Table 29 : Asia-Pacific Market for Targeted Therapeutics, by Country, Through 2026
Table 30 : Rest of the World Market for Targeted Therapeutics, by Type, Through 2026
Table 31 : Rest of the World Market for Targeted Therapeutics, by Application, Through 2026
Table 32 : Revenue: Selected Targeted Therapeutics, 2019 and 2020
Table 33 : Oncology Drug Licensing Deals, 2020
Table 34 : Oncology Merger and Acquisition Deals, 2020
Table 35 : Selected Targeted Therapeutics in Phase I Clinical Trials, 2021
Table 36 : Selected Targeted Therapeutics in Phase II Clinical Trials, 2021
Table 37 : Selected Targeted Therapeutics in Phase III Clinical Trials, 2021
Table 38 : Selected Targeted Therapeutics in Phase IV Clinical Trials, 2021
Table 39 : Amgen Inc.: Marketed Products, 2020
Table 40 : AstraZeneca: Marketed Products, 2020
Table 41 : Bayer AG: Marketed Products, 2020
Table 42 : Boehringer Ingelheim International GmbH: Marketed Products, 2020
Table 43 : Bristol-Myers Squibb: Marketed Products, 2020
Table 44 : Bristol-Myers Squibb: Selected Product Approvals, 2020-2021
Table 45 : F. Hoffmann-La Roche Ltd.: Marketed Products, 2020
Table 46 : Merck & Co., Inc.: Marketed Products, 2020
Table 47 : Merck & Co., Inc.: Selected Product Approvals, 2020
Table 48 : Novartis AG: Marketed Products, 2020
Table 49 : Pfizer: Marketed Products, 2020
Table 50 : Takeda Pharmaceutical Co., Ltd.: Marketed Products, 2020
Table 51 : Takeda Pharmaceutical Co., Ltd.: Selected Product Approval, 2020-2021
Table 52 : Acronyms Used in This Report

List of Figures

Summary Figure : Global Market Shares of Targeted Therapeutics, by Type, 2020
Figure 1 : Global Estimated Cancer Cases, All Ages, by Cancer Type, 2020
Figure 2 : Global Estimated Cancer Cases, All Ages, 2020
Figure 3 : Global Estimated Cancer Related Deaths, All Ages, 2020
Figure 4 : Distribution of New Cancer Cases in Women, 2020
Figure 5 : Distribution of New Cancer Cases in Men, 2020
Figure 6 : Global Estimated New Cancer Cases, by Region, 2020 vs. 2040
Figure 7 : National Cancer Institute Research Funding, 2012-2019
Figure 8 : Global Market Shares of Targeted Therapeutics, by Type, 2020
Figure 9 : Global Market for Cancer Small Molecule Therapy, 2019-2026
Figure 10 : Global Market for Cancer Small Molecule Therapy, by Region, 2019-2026
Figure 11 : Global Market for Cancer Monoclonal Antibody Therapy, 2019-2026
Figure 12 : Global Market for Cancer Monoclonal Antibody Therapy, by Region, 2019-2026
Figure 13 : Approved Antibody Therapeutics in the U.S. and EU, 2010-2020
Figure 14 : Global Market Shares of Targeted Therapeutics, by Application, 2020
Figure 15 : Global Market for Targeted Therapeutics for Lung Cancer, 2019-2026
Figure 16 : Global Market for Targeted Therapeutics for Lung Cancer, by Region, 2019-2026
Figure 17 : Prevalence of Lung Cancer Cases, by Continent, 2015-2020
Figure 18 : Global Market for Targeted Therapeutics for Breast Cancer, 2019-2026
Figure 19 : Global Market for Targeted Therapeutics for Breast Cancer, by Region, 2019-2026
Figure 20 : Prevalence of Breast Cancer Cases, by Continent, 2015-2020
Figure 21 : Global Market for Targeted Therapeutics for Blood Cancer, 2019-2026
Figure 22 : Global Market for Targeted Therapeutics for Blood Cancer, by Region, 2019-2026
Figure 23 : Share of New Blood Cancer Cases in the U.S., by Cancer Type, 2021
Figure 24 : Global Market for Targeted Therapeutics for Colorectal Cancer, 2019-2026
Figure 25 : Global Market for Targeted Therapeutics for Colorectal Cancer, by Region, 2019-2026
Figure 26 : Prevalence of Colorectal Cancer Cases, by Continent, 2015-2020
Figure 27 : Global Market for Targeted Therapeutics for Other Types of Cancer, 2019-2026
Figure 28 : Global Market for Targeted Therapeutics for Other Types of Cancer, by Region, 2019-2026
Figure 29 : Global Market for Targeted Therapeutics, by Region, 2019-2026
Figure 30 : North American Market Shares of Targeted Therapeutics, by Type, 2020
Figure 31 : North American Market Shares of Targeted Therapeutics, by Application, 2020
Figure 32 : North American Market Shares of Targeted Therapeutics, by Country, 2020
Figure 33 : U.S. Market for Targeted Therapeutics, 2019-2026
Figure 34 : Canadian Market for Targeted Therapeutics, 2019-2026
Figure 35 : European Market Shares of Targeted Therapeutics, by Type, 2020
Figure 36 : European Market Shares of Targeted Therapeutics, by Application, 2020
Figure 37 : European Market Shares of Targeted Therapeutics, by Country, 2020
Figure 38 : German Market for Targeted Therapeutics, 2019-2026
Figure 39 : U.K. Market for Targeted Therapeutics, 2019-2026
Figure 40 : French Market for Targeted Therapeutics, 2019-2026
Figure 41 : Italian Market for Targeted Therapeutics, 2019-2026
Figure 42 : Spanish Market for Targeted Therapeutics, 2019-2026
Figure 43 : Rest of European Market for Targeted Therapeutics, 2019-2026
Figure 44 : Asia-Pacific Market Shares of Targeted Therapeutics, by Type, 2020
Figure 45 : Asia-Pacific Market Shares of Targeted Therapeutics, by Application, 2020
Figure 46 : Asia-Pacific Market Shares of Targeted Therapeutics, by Country, 2020
Figure 47 : Chinese Market for Targeted Therapeutics, 2019-2026
Figure 48 : Indian Market for Targeted Therapeutics, 2019-2026
Figure 49 : Japanese Market for Targeted Therapeutics, 2019-2026
Figure 50 : Rest of Asia-Pacific Market for Targeted Therapeutics, 2020-2026
Figure 51 : Rest of the World Market Shares of Targeted Therapeutics, by Type, 2020
Figure 52 : Rest of the World Market Shares of Targeted Therapeutics, by Application, 2020
Figure 53 : Company Share Analysis of the Global Targeted Therapeutics Market, 2020
Figure 54 : Distribution of Clinical Trials on Targeted Therapeutics, by Phase, 2021
Figure 55 : Amgen Inc.: Annual Revenue, 2018-2020
Figure 56 : Amgen Inc.: Revenue Share, by Product Sales, 2020
Figure 57 : Amgen Inc.: Revenue Share, by Geography, 2020
Figure 58 : AstraZeneca: Annual Revenue, 2018-2020
Figure 59 : AstraZeneca: Oncology Segment Revenue, 2018-2020
Figure 60 : AstraZeneca: Revenue Share, by Geography, 2020
Figure 61 : Bayer AG: Annual Revenue, 2018-2020
Figure 62 : Bayer AG: Revenue Share, by Segment, 2020
Figure 63 : Bayer AG: Revenue Share, by Geography, 2020
Figure 64 : Boehringer Ingelheim International GmbH: Annual Revenue, 2018-2020
Figure 65 : Boehringer Ingelheim International GmbH: Revenue Share, by Segment, 2020
Figure 66 : Boehringer Ingelheim International GmbH: Revenue Share, by Geography, 2020
Figure 67 : Bristol-Myers Squibb: Annual Revenue, 2018-2020
Figure 68 : Bristol-Myers Squibb: Revenue Share, by Geography, 2020
Figure 69 : F. Hoffmann-La Roche Ltd.: Annual Revenue, 2018-2020
Figure 70 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2020
Figure 71 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2020
Figure 72 : Merck & Co., Inc.: Annual Revenue, 2018-2020
Figure 73 : Merck & Co., Inc.: Revenue Share, by Segment, 2020
Figure 74 : Merck & Co., Inc.: Revenue Share, by Geography, 2020
Figure 75 : Novartis AG: Financial Performance, 2018-2020
Figure 76 : Novartis AG: Revenue Share, by Segment, 2020
Figure 77 : Novartis AG: Revenue Share, by Geography, 2020
Figure 78 : Pfizer: Annual Revenue, 2018-2020
Figure 79 : Pfizer: Oncology Segment Revenue, 2018-2020
Figure 80 : Pfizer: Revenue Share, by Geography, 2020
Figure 81 : Takeda Pharmaceutical Co., Ltd.: Annual Revenue, 2018-2020
Figure 82 : Takeda Pharmaceutical Co., Ltd.: Revenue Share, by Segment, 2020
Figure 83 : Takeda Pharmaceutical Co., Ltd.: Revenue Share, by Geography, 2020



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。